There is a conversation that happens at the end of almost every rosacea treatment course. The
bumps have gone. The face is calmer. And the redness is still there, along with the fine vessels
across the cheeks and the nose that never seemed to respond to anything. That conversation is where
most people first hear about IPL for rosacea.
That is not a failure of your treatment. It is a limit built into how those treatments work.
Creams and tablets act on inflammation and on organisms. Neither of those things is a blood vessel.
IPL for rosacea exists because the vascular part of this disease needs a different
kind of tool, and it is worth understanding properly before you spend money on a course of six
sessions.
Quick answer
IPL for rosacea treats redness and visible vessels, which most rosacea drugs do not
touch. Filtered broad-spectrum light is absorbed by oxyhaemoglobin, heating and collapsing
superficial vessels. Randomised split-face work shows significant reductions in erythema and
telangiectasia, and light therapy also improves meibomian gland function, which matters because
around 80% of people with facial rosacea have meibomian gland dysfunction. It is
not a Demodex treatment: the one study reporting an eradication rate put it at
20%. A 2024 meta-analysis found no significant difference between IPL and pulsed dye laser on
erythema.
What IPL for rosacea is, and what it is not
IPL stands for intense pulsed light. It is not a laser. A laser emits one
wavelength; IPL emits a broad band, usually somewhere between 500 and 1200 nanometres, and filters
cut off the parts that are not wanted.
The target is oxyhaemoglobin, the pigment in red blood cells. It absorbs light
strongly in certain parts of that band. Absorbed light becomes heat, the heat damages the vessel
wall, and the vessel collapses and is cleared away over the following weeks.
That is the entire mechanism for the skin. Everything else IPL is credited with is a side effect
of putting heat into tissue.
What the evidence for IPL for rosacea supports
Redness and vessels genuinely improve. A
randomised, single-blind, split-face trial
in moderate erythematotelangiectatic rosacea compared non-purpuragenic pulsed dye laser against IPL
with an untreated control area on the same face, over three monthly sessions. Both produced
significant reductions in erythema, telangiectasia and patient-reported symptoms. Having an
untreated control on the same person is what makes that design worth quoting.
Larger comparisons agree, and add a caveat. A
retrospective analysis of 112 patients
found narrow-band IPL outperformed both pulsed dye laser and broad-band IPL on erythema reduction,
suggesting that the filter matters more than the category.
The eyes improve too. Light therapy has become a standard second-step option for
evaporative dry eye, after lid hygiene and lubricants, in the main international treatment
algorithm. The mechanism is thermal: heat softens thickened meibum so blocked glands express again.
The comparison that deflates the marketing
A 2024
meta-analysis
pooled the studies comparing IPL for rosacea against pulsed dye laser, the older vascular standard.
On erythema index there was no statistically significant difference between them,
with a standardised mean difference of -0.15 and a confidence interval crossing zero.
IPL held a slight edge on the proportion of patients reaching more than 75% clearance, and
pulsed dye laser tends to suit people with lower tolerance for discomfort. But the headline is that
two technologies marketed very differently produced results a meta-analysis could not separate.
Read that as permission to stop shopping for a device brand. What varies more than the machine
is the operator, the settings and whether anyone measured your baseline.
The weakest part of the evidence
The ocular literature is thinner than the skin literature, and it is worth knowing that before a
clinic quotes it at you.
Most of the eye studies are retrospective series of twenty to thirty patients,
often without a control group and often using different devices, filters, energy levels and session
intervals. A systematic review concluded that the therapeutic value of light therapy for dry eye
remained uncertain, specifically because adequately powered randomised trials were scarce.
Sham-controlled work has since appeared and has been more encouraging, and the international dry
eye treatment algorithm now lists the modality as a second-step option. But results are also
inconsistent within studies: one series reported improvements in tear break-up time and lipid layer
thickness while symptom scores, tear osmolarity and gland loss stayed exactly where they were.
None of that makes IPL for rosacea a bad option for the eyes. It makes it an option with real
but uneven support, which is a different sentence from the one in most clinic brochures.
Does IPL for rosacea kill Demodex mites?
Partly, and much less than the marketing implies.
The mechanism is plausible. Demodex sits in follicles and glands close to the surface, heat is
delivered into that tissue, and coagulating the small vessels that supply an inflamed lid margin
plausibly changes the local environment.
The measured result is more sober. In a retrospective study of 25 patients who had four IPL
sessions over 42 days, the reported Demodex eradication rate was 20%, alongside
genuine improvements in meibomian gland function and morphology. Twenty percent means four out of
five patients still had mites at the end of a full course.
So IPL for rosacea reduces mite load in some people, and clears it in a minority. If Demodex
density is a documented part of your picture, it needs a plan of its own running alongside, and
keeping that result requires the kind of ongoing schedule set out in our guide to
stopping Demodex coming back.
It does nothing at all for Malassezia. There is no mechanism and no evidence. If your
bumps are itchy, uniform and worse across the forehead and chest, the answer is not a light device,
and the yeast side of the problem is
covered separately.
The eye half of the IPL for rosacea story
This is the part patients are rarely told, and it is the strongest practical argument for seeing
the two problems together.
Around 80% of people with facial rosacea have meibomian gland dysfunction, and
in roughly a fifth of rosacea patients the eye signs appear before the skin signs. The same
treatment session that targets the vessels on your cheeks can be extended to the lid margin.
The catch is that the two specialties do not usually talk to each other. A skin clinic treats the
face and does not examine the eyes; an eye clinic treats the lids and rarely assesses the skin. Our
article on why clear skin does not mean clear
eyes explains why grading them separately matters, and it is worth reading before you book
anything.
Practical version: have your eyes assessed first. If there is meibomian gland dysfunction, say so
when you book, because it changes where the practitioner treats.
Who IPL for rosacea suits, and who it does not
It suits the person whose main complaint is redness, flushing or visible vessels,
whose inflammatory bumps are already controlled, and who understands they are buying an improvement
rather than an ending.
It suits people with coexisting dry eye and meibomian gland dysfunction particularly well,
because one course can address both.
Skin tone matters and is often glossed over. IPL is absorbed by melanin as well
as by haemoglobin. In deeper skin tones the risk of burns and pigment change rises, and most
published rosacea studies enrolled lighter skin types. This does not rule anyone out, but it does
mean asking the clinic directly what experience they have with your skin, and expecting more
conservative settings.
Photosensitising medicines matter too. Several rosacea treatments increase light
sensitivity, oral tetracyclines and oral retinoids among them. Tell the clinic everything you take,
including supplements. If you are on a course of
doxycycline, that is a conversation to
have before the first session, not after.
It suits you least if you are hoping to treat the bumps. Papulopustular disease responds to
anti-inflammatory and acaricidal therapy, and the phenotype distinctions that decide this are set
out in rosacea types 1 to 4.
What to expect from a course of IPL for rosacea
Courses, not single sessions. Published protocols for IPL for rosacea
cluster around three to four sessions at intervals of two to six weeks, with assessment a few weeks
after the last one.
It is uncomfortable, briefly. Most people describe a hot snap against the skin.
Redness and mild swelling for a day or two afterwards is normal.
Maintenance is the norm. Rosacea is a relapsing disease. Vessels can reappear,
and most protocols expect top-up sessions. Anyone promising permanence is describing something the
literature does not.
Ask how it will be measured. Erythema can be scored with a clinician scale or
photographed under standardised imaging. If nobody records a baseline, nobody can tell you honestly
whether it worked.
For practitioners
Positioning. IPL for rosacea occupies the vascular endpoint that
pharmacological therapy consistently fails to move. It is complementary to, not competitive with, anti-inflammatory and
acaricidal treatment, and is best sequenced after inflammatory lesions are controlled.
Evidence quality. Split-face randomised data with an untreated control support
erythema and telangiectasia reduction. The 2024 meta-analysis against pulsed dye laser found no
significant difference in erythema index (SMD -0.15, 95% CI -0.55 to 0.26), with a modest IPL
advantage in achieving greater than 75% clearance. Ocular evidence is weaker: predominantly
retrospective series and small trials, and systematic review has previously judged the therapeutic
value uncertain for want of adequately powered randomised data.
The Demodex claim. A 20% eradication rate in a single retrospective series of
25 patients is the honest ceiling on what can be claimed. IPL should not be substituted for
acaricidal therapy where density is documented, and no study has assessed IPL against a standardised
skin surface biopsy endpoint on facial skin.
Safety. Melanin competes as a chromophore, so fluence must be reduced in higher
Fitzpatrick phototypes and the published rosacea literature skews to lower phototypes. Screen for
photosensitising drugs, recent tanning and isotretinoin use, and use appropriate intraocular or
external eye shields for periocular treatment.
Combined pathway. Given the prevalence of meibomian gland dysfunction in facial
rosacea, an ocular surface assessment before a facial IPL course identifies patients for whom lid
margin treatment should be included rather than deferred.
Frequently asked questions
How many sessions of IPL for rosacea are needed?
Published protocols usually run three to four sessions spaced two to six weeks apart, with
assessment a few weeks after the last. Maintenance sessions are generally expected afterwards.
Does IPL for rosacea get rid of Demodex mites?
Not reliably. The one study reporting an eradication rate found 20% after four sessions, meaning
most patients still had mites. It can lower the load but it is not a substitute for acaricidal
treatment.
Is IPL for rosacea better than laser?
A 2024 meta-analysis found no significant difference in erythema reduction between IPL and pulsed
dye laser. IPL had a slight edge on high-clearance rates; pulsed dye laser is often preferred where
discomfort tolerance is low.
Is IPL for rosacea safe on darker skin?
It requires more caution. IPL is absorbed by melanin as well as haemoglobin, so the risk of burns
and pigment change rises in deeper skin tones, and most published rosacea studies enrolled lighter
skin types. Ask the clinic directly about their experience with your skin.
Will IPL help my dry, gritty eyes as well as my face?
Often, yes. Light therapy is an established second-step option for evaporative dry eye, and about
80% of people with facial rosacea have meibomian gland dysfunction. Have the eyes assessed first so
the lid margin can be included.
Can I have IPL while taking doxycycline or isotretinoin?
Both raise light sensitivity, so this needs discussing with the clinic in advance. It is not an
automatic exclusion, but it changes timing and settings and should never be left undisclosed.
References
- Neuhaus IM, Zane LT, Tope WD. Comparative efficacy of nonpurpuragenic pulsed dye laser and
intense pulsed light for erythematotelangiectatic rosacea. Dermatol Surg. 2009;35(6):920-928.
PMID 19397667. - Zhai L, et al. Meta-analysis of the Efficacy of Intense Pulsed Light and Pulsed-Dye Laser
Therapy in the Management of Rosacea. J Cosmet Dermatol. 2024. PMC11626304. - Comparison of the efficacy and safety of pulsed dye laser, narrow-band intense pulsed light,
and broad-band intense pulsed light in the treatment of erythematotelangiectatic rosacea. 2025.
PMC12351582. - Cheng SN, Jiang FG, Chen H, et al. Intense Pulsed Light Therapy for Patients with Meibomian
Gland Dysfunction and Ocular Demodex Infestation. Curr Med Sci. 2019;39(5):800-809. - Dell SJ. Intense pulsed light for evaporative dry eye disease. Clin Ophthalmol.
2017;11:1167-1173. - Jones L, Downie LE, Korb D, et al. TFOS DEWS II Management and Therapy Report. Ocul Surf.
2017;15(3):575-628. - Intense pulsed light treatment in meibomian gland dysfunction: A concise review. Ocul Surf.
2020. - Piyacomn Y, Kasetsuwan N, Reinprayoon U, et al. Efficacy and Safety of Intense Pulsed Light in
Patients With Meibomian Gland Dysfunction: A Randomized, Double-Masked, Sham-Controlled Clinical
Trial. Cornea. 2020;39(3):325-332. - Tan J, Almeida LMC, Bewley A, et al. Updating the diagnosis, classification and assessment of
rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol.
2017;176(2):431-438. PMID 27718519.
Not sure whether mites are part of your picture? Start with the
Demodex self-assessment quiz, or browse the full
clinical library. To find a clinician who works
with these conditions, see the practitioner
directory.
About the author. Marina Ivakhnenko is a
functional skin practitioner who works with Demodex-related skin and eyelid conditions, and
writes the clinical education library at demodex.net/. This article is educational and is not a
substitute for individual medical care. Treatments discussed here are prescription medicines in
most countries and decisions about them belong with your own clinician.